apolipoprotein C-III
Apolipoprotein C III(Lys58 Glu) Identification of an apolipoprotein C III variant in a family with hyperalphalipoproteinemia
... Apolipoprotein C-III is a major protein constituent of triglyceride rich lipoproteins and ...Apo C-III putatively inhibits lipolysis and the apo E mediated hepatic uptake of remnants ...
9
The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism
... encoding apolipoprotein C-III (apoCIII) and relevant hypotriglyceremia are associated with decreased CVD risk (40–41 %) [4, ...an apolipoprotein composed of 79 amino acids with a molecular ...
7
Modulation of lipoprotein lipase activity by apolipoproteins Effect of apolipoprotein C III
... and apolipoprotein levels present in the lipoprotein fraction (d less than ...only apolipoprotein C-III (ApoC-III) was significantly correlated (r = ...or apolipoprotein E ...
8
D25V apolipoprotein C III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile
... | Apolipoprotein C-III amyloidosis in a French ...of C-482T and T-455C polymorphisms is ...from III.3 in b and IV.3 in c show a congested liver and amyloid in the spleen and ...
15
Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levels
... Extractions of cellular proteomes were independently performed on 3 different mice for each TG level group (WT, HE) (total number of samples: 3×2 = 6). Total cellular proteome was extracted from liver homogenized in ...
16
Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels
... Plasma apolipoprotein (Apo) C-III is a major compo- nent of TG-rich lipoproteins (chylomicrons and very low density lipoprotein) and a minor component of high density ...a C®G substitution at ...
10
Haptoglobin α1, α2, vitamin D binding protein and apolipoprotein C III as predictors of etanercept drug response in rheumatoid arthritis
... ApoC- III exerts proinflammatory effects on both monocytes and endothelial cells during the pathogenesis of athero- sclerosis: ApoC-III was previously shown to induce the expression of intercellular ...
12
An abnormal triglyceride rich lipoprotein containing excess sialylated apolipoprotein C III
... apo C-III-2 band with a corresponding increase in the region of apo C-III-0, which suggests that the increased content of apo C-III-2 in the abnormal is due to excessive ...
9
Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials
... apo C-III and (3) presentation of sufficient information on apo C-III concentrations at baseline and at study end in both inter- vention and placebo groups or providing the net change ...apo ...
9
Apolipoprotein C III 1 activates lysosomal sphingomyelinase in vitro
... Apolipoprotein (apo)C-III-1 from human very low density lipoprotein stimulates 14-fold the activity of lysosomal sphingomyelinase from human fibroblasts. At the sphingomyelin concentrations tested, ...
6
Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)
... also is reported to reduce remnant-like particle cholesterol (RLP-C) levels in MARINE and ANCHOR [61] using an immunoseparation assay [62–64]. Remnant lipoproteins are partially catabolized TG-rich lipoproteins, ...
13
Apolipoprotein C1 Association with Hepatitis C Virus
... Production of pseudotyped virus. Three million 293T cells were seeded in 100-mm flat culture dishes and allowed to adhere overnight. Cells were trans- fected with Lipofectamine Plus reagents (Invitrogen) per the supplied ...
10
Molecular characterization of Tunisian families with abetalipoproteinemia and identification of a novel mutation in MTTP gene
... and reduction in the osteotendinous reflexes. The patient was treated, during one year, by oral vitamin A 25 000 IU daily, vitamin E 800 mg daily, and vitamin K 40 mg every 15 days, the postprandial vomiting, walk and ...
7
Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
... sensitivity C-reactive protein were normal overall based on the standard lipid ...reduced apolipoprotein B and the apolipoprotein B to apolipoprotein A1 ratio (P , ...sensitivity ...
9
Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention
... vessel disease, we introduced a multiplicative interaction term and ApoB/ApoA1 ratio quartiles as continuous variables and added these variables to the aforemen- tioned multivariate model. In the subgroup analyses, the ...
9
Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus
... able apolipoprotein that participates in lipid transport by interact- ing with the low-density lipoprotein receptor (LDL-R) and ...nonexchangeable apolipoprotein that remains associated with the lipoprotein ...
12
C-III Acts
... Forschergruppe C-II Images, den Ortwin Dally, Susanne Moraw und Hauke Ziemssen 2009 organisiert haben (»Bild – Raum – Handlung«), wurde daher dem Studium von Bildern als Elemen- ten ortsübergreifender Handlungen ...
16
Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3 Structure and genetics of an apolipoprotein E3 variant
... heterozygous for this variant, suggesting that the disorder in this family is transmitted in a dominant fashion. The variant apo E3 was defective in its ability to bind to lipoprotein receptors, and this functional ...
8
The association between the apolipoprotein A1/ high density lipoprotein -cholesterol and diabetes in Taiwan — a cross-sectional study
... and apolipoprotein composition of HDL in the metabolic syn- drome was obviously changed with impaired beneficial function and more readily detected the ApoA-I level ...
8
Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study
... Study subjects were evaluated at the Clinical and Trans- lational Research Center (CTRC) at HUP after a 12- hour fast. They completed a questionnaire regarding past medical, social, and family history as well as use of ...
8